Medicine Description ryzodeg 100 i.u./ml
ryzodeg 100 i.u. / ml prefilled pen is a medication that combines two types of insulin: insulin degludec and insulin aspart. Insulin degludec provides a long-acting background insulin effect, ensuring a stable basal level of insulin over an extended period. This helps to control blood sugar levels throughout the day and night. Insulin aspart is a rapid-acting insulin that facilitates quick glucose uptake from the bloodstream following meals. By combining these two insulins, Ryzodeg offers a versatile treatment option, mimicking the natural insulin response of the body more closely than using either type of insulin alone. This dual-action helps manage blood glucose levels effectively in patients with diabetes, allowing for flexibility in meal timing and lifestyle adjustments.
Indications and Uses of ryzodeg 100 i.u. / ml prefilled pen
- Management of hyperglycemia in adults with type 1 diabetes.
- Management of hyperglycemia in adults with type 2 diabetes.
- Used as part of a basal-bolus insulin regimen.
Side Effects of ryzodeg 100 i.u. / ml prefilled pen
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling, itching)
- Weight gain
- Allergic reactions
- Hypersensitivity reactions
Storage and Handling
Store the Ryzodeg prefilled pen in the refrigerator between 2°C and 8°C until first use. After first use, the pen can be kept at room temperature, not exceeding 30°C, for up to 56 days. Do not freeze the pen, and protect it from light.
Patient Advice and Precautions
Always monitor blood sugar levels regularly to adjust insulin doses as needed.Be aware of the signs of hypoglycemia and carry a source of fast-acting sugar at all times.Do not share the pen with others to prevent infections.Consult a healthcare provider if experiencing persistent nausea, vomiting, or unusual weight changes.Educate yourself on proper injection techniques and sites to minimize discomfort and complications.